News for 'research-director'

Apple hits record 28% value share in India

Apple hits record 28% value share in India

Rediff.com2 Feb 2026

Tech giant Apple has recorded its highest-ever value share of 28 per cent in the Indian smartphone market, driven by a surging "premiumisation" trend where consumers are increasingly opting for high-end devices, according to a report by Counterpoint Research.

NatWest Wants To Hire 3,000 Engineers In India

NatWest Wants To Hire 3,000 Engineers In India

Rediff.com10 Oct 2025

With 18,000 employees already, NatWest eyes 3,000 engineers in India by next year to strengthen its AI and data capabilities.

AI Phones Catch India's Eye

AI Phones Catch India's Eye

Rediff.com13 Oct 2025

GenAI smartphones are mobile devices that leverage large-scale, pre-trained GenAI models to create original content or perform contextually aware tasks.

Entry-level 5G smartphone market hots up ahead of festival season

Entry-level 5G smartphone market hots up ahead of festival season

Rediff.com19 Sep 2025

India's entry-level 5G smartphone segment, typically held to be those priced below 10,000, is set to bustle in the upcoming festival season as brands like HMD, Poco, and Lava launch their products.

'We Are Not Listening To The Alarms'

'We Are Not Listening To The Alarms'

Rediff.com29 Aug 2025

'What we are witnessing is not a freak incidence or a freak occurrence, but a new climate reality where warming oceans, monsoon variability and local geography are combining to produce extreme events.'

Growth to remain muted for IT services firms in Q1 amid macro uncertainty

Growth to remain muted for IT services firms in Q1 amid macro uncertainty

Rediff.com7 Jul 2025

Indian information technology (IT) service providers are expected to deliver low single-digit sequential growth in the first quarter (April-June) of 2025-26 (FY26), even as macroeconomic uncertainties continue to persist due to the volatile geopolitical environment.

No tariffs, no US sales: Trump's warning to Apple on India production

No tariffs, no US sales: Trump's warning to Apple on India production

Rediff.com24 May 2025

US President Donald Trump has threatened to impose tariffs on Apple products if the tech giant does not shift iPhone production from India to the United States. Trump said he expects iPhones sold in the US to be manufactured in America and not India, or anyplace else. He also said that he had a "little problem" with Apple CEO Tim Cook for building manufacturing facilities in India. Cook had previously said that the majority of iPhones sold in the US would have India as their country of origin. Experts say that shifting production to the US would be more expensive than assembling iPhones in India.

'Media Frenzy Has Ruined Justice Varma's Reputation'

'Media Frenzy Has Ruined Justice Varma's Reputation'

Rediff.com16 Apr 2025

'Presumption of innocence must guide all formal actions, but transparency must not be mistaken for pre-judgment.' 'The cruel irony, however, is that Justice Varma is a fine judge who enjoys a reputation for writing well-reasoned judgments.'

'Poorly designed': ICMR on BHU Covaxin safety study

'Poorly designed': ICMR on BHU Covaxin safety study

Rediff.com20 May 2024

The method of data collection has a high risk of bias, the ICMR DG said.

How The Heat Wave Will Affect Your Kitchen

How The Heat Wave Will Affect Your Kitchen

Rediff.com2 May 2024

Apart from the human body, human food will bear direct repercussions. From staples such as wheat, to coffee, dairy, and even the great Hilsa face the threat of reduced supply due to the extreme heat.

Merrill's stock research director Deepak Raj quits

Merrill's stock research director Deepak Raj quits

Rediff.com15 Feb 2003

Merrill Lynch & Co Inc, said on Friday that Deepak Raj, who headed its global stock research team while it was the target of state and federal investigations, is leaving the Wall Street firm one week after his boss, Robert McCann, resigned.

Nipah mortality rate much higher than Covid, says ICMR

Nipah mortality rate much higher than Covid, says ICMR

Rediff.com16 Sep 2023

He asserted that all efforts are on to contain the spread of the virus in Kerala.

'Supreme Court verdict on Article 370 is a missed opportunity'

'Supreme Court verdict on Article 370 is a missed opportunity'

Rediff.com11 Jan 2024

'On hard cases like this one, the Supreme Court has only episodically stood against Parliament and the executive government.' 'I worry that this decision sets a precedent where President's rule is imposed in another state... and during the operation of President's rule, the state is fundamentally altered.'

Why Article 370 Failed To Protect Kashmiri Pandits

Why Article 370 Failed To Protect Kashmiri Pandits

Rediff.com11 Aug 2023

'The relationship between Kashmiri Pandits and Article 370 is vexed.' 'Sentiment in Jammu towards Article 370 was largely unfavourable and Jammu resented being lumped with Kashmir and placed on a different footing from the rest of India.'

'Incorrect to say Article 370 has been abrogated'

'Incorrect to say Article 370 has been abrogated'

Rediff.com5 Aug 2023

'Article 370 laid down the edifice of the relationship between J-K and the Union of India.' 'If you look at the Article, what is there now is a provision which states that all provisions of the Constitution of India applies to J-K.' 'The veto that the state could exercise previously on most Union laws has ended.'

Centre advises use of mask in crowded areas amid fresh Covid scare

Centre advises use of mask in crowded areas amid fresh Covid scare

Rediff.com21 Dec 2022

He urged people not to panic and clarified that there was no change in the guidelines for international air travel so far.

'Only time will tell if we can save Joshimath'

'Only time will tell if we can save Joshimath'

Rediff.com10 Jan 2023

'All hydropower projects in the Himalayan region must be stopped.' 'Joshimath is not alone.'

Covid-positive ICMR chief admitted to AIIMS

Covid-positive ICMR chief admitted to AIIMS

Rediff.com18 Dec 2020

Bhargava, who is also a cardiologist, had tested positive for coronavirus infection around 7-8 days ago and was under home isolation

Indian corporate houses face a sharp, abrupt increase in funding costs

Indian corporate houses face a sharp, abrupt increase in funding costs

Rediff.com28 Jun 2022

After two years of a record low interest-rate regime, Indian corporate houses are experiencing a sharp and abrupt increase in funding costs. With the Reserve Bank of India last month making an unequivocal turn towards policy tightening amid high inflation, firms looking to tap the capital markets for funds are ending up shelling out more. The yield on the benchmark triple-A-rated corporate bonds maturing in three years has climbed 98 basis points (bps) since the policy rate hike in May. It was last at 7.47 per cent, Bloomberg data showed.

Oxygen supply up by nearly 4 times from Feb to April: Govt sources

Oxygen supply up by nearly 4 times from Feb to April: Govt sources

Rediff.com20 Apr 2021

The health ministry further informed that in addition to 162 plants already sanctioned, the states have requested Centre for more than 100 such additional plants which are also being sanctioned.

World University Rankings: Non-IITs in Top 100

World University Rankings: Non-IITs in Top 100

Rediff.com11 Apr 2022

The Saveetha Institute of Medical and Technical Sciences. The Indian School of Mines, Dhanbad. Vinay Umarji explains why these two universities have made India proud.

Younger more affected by Covid as they're going out: ICMR

Younger more affected by Covid as they're going out: ICMR

Rediff.com11 May 2021

In response to a question on whether younger population were getting more affected, Indian Council of Medical Research Director General Dr Balram Bhargava said the comparison of data during the first and the second wave of COVID-19 has shown that there is not much age difference.

COVID-19: Govt bans export of anti-malarial drug

COVID-19: Govt bans export of anti-malarial drug

Rediff.com25 Mar 2020

Indian Council of Medical Research Director General Balram Bhargava had on Monday recommended the use of hydroxychloroquine for treating healthcare workers handling suspected or confirmed coronavirus cases.

'Untenable': India's top health experts on WHO report on Covid deaths

'Untenable': India's top health experts on WHO report on Covid deaths

Rediff.com6 May 2022

These kinds of assumptions to be used for a nation of India's size and "to put us in poor light is not desirable"

Maharashtra Covid-19 situation very worrying, says Centre

Maharashtra Covid-19 situation very worrying, says Centre

Rediff.com11 Mar 2021

"We are very worried about the rise in cases in Maharashtra. Don't take this virus for granted. It can come up unexpectedly. If we have to remain free of this virus, COVID-appropriate behaviour, containment strategy as well as vaccination has to be brought in," Paul said.

Covid spread higher than 2nd wave peak: Govt

Covid spread higher than 2nd wave peak: Govt

Rediff.com5 Jan 2022

The Centre said the upsurge of COVID-19 cases is happening in cities and the Omicron variant is the predominant circulating strain.

Deaths in Covid 3rd wave much lower than in 2nd wave, says govt

Deaths in Covid 3rd wave much lower than in 2nd wave, says govt

Rediff.com20 Jan 2022

Deaths are significantly less in the third wave of the Covid-19 pandemic in comparison to the second wave, and the current surge is not witnessing increase in severe illness or death following high vaccination uptake, the government said on Thursday.

111 Omicron cases in India now after highest single-day rise

111 Omicron cases in India now after highest single-day rise

Rediff.com17 Dec 2021

People must also avoid mass gatherings, and new year celebrations need to be at low intensity, the government said.

Covaxin safe, shows 77.8% efficacy against symptomatic Covid: Lancet

Covaxin safe, shows 77.8% efficacy against symptomatic Covid: Lancet

Rediff.com12 Nov 2021

The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.

'Covid vaccine will be equally effective against new mutant'

'Covid vaccine will be equally effective against new mutant'

Rediff.com21 Dec 2020

The CSIR DG said the transmissibility of the new strain N501Y is a "bit higher" but this does not mean it is more lethal and more people are going to die due to it.

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Rediff.com15 Sep 2020

Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, minister of state for health Ashwini Choubey informed the Rajya Sabha on Tuesday.

25% of Indians have received 2 vax doses, 69% at least one jab

25% of Indians have received 2 vax doses, 69% at least one jab

Rediff.com30 Sep 2021

Thirty districts in the country, including 13 in Kerala, eight in Mizoram, four in Meghalaya, three each in Manipur and Arunachal Pradesh, two in Sikkim and one in Meghalaya are reporting a weekly positivity rate of over 10 per cent.

Covishield, Covaxin work against Delta, other variants: Govt

Covishield, Covaxin work against Delta, other variants: Govt

Rediff.com25 Jun 2021

Vaccines Covishield and Covaxin work against SARS-CoV-2 variants Alpha, Beta, Gamma and Delta, while effectiveness tests against the Delta Plus variant is ongoing, the government said.

Xiaomi maintains No.1 position in a bad year for smartphones

Xiaomi maintains No.1 position in a bad year for smartphones

Rediff.com16 Feb 2021

The first half of the year (H1-2020) was marked by sluggish growth with demand down 26 per cent YoY, while the second half saw recovery. H2-2020 recovered with 19 per cent YoY growth, reports Shivani Shinde.

Russia seeks Indian help in manufacturing COVID-19 vaccine

Russia seeks Indian help in manufacturing COVID-19 vaccine

Rediff.com26 Aug 2020

According to government sources, the matter was discussed by the national expert group on vaccine administration for COVID-19 in its last meeting held on August 22.

Mobile phone production down 50% amid Covid-19 surge

Mobile phone production down 50% amid Covid-19 surge

Rediff.com12 May 2021

According to research firm IDC, a slowdown in smartphone shipments began showing up as early as late February, though companies insist that the March quarter was fine, albeit on a low base.

Half of India's Covid victims older than 60 yrs: Govt

Half of India's Covid victims older than 60 yrs: Govt

Rediff.com4 Aug 2020

Union health secretary Rajesh Bhushan said 50 districts account for 66 per cent of the total caseload and the COVID-19 case fatality rate has progressively declined to 2.10 per cent, the lowest since the first lockdown was imposed on March 25.

BEWARE! Fraud Journals On The Rise

BEWARE! Fraud Journals On The Rise

Rediff.com27 Nov 2021

Cloned journals have become more rampant in the post-pandemic world.

iPhone 13 to go on sale in India from September 24

iPhone 13 to go on sale in India from September 24

Rediff.com15 Sep 2021

The wait for the new iPhone is over as the tech giant Apple officially launched its new iPhone 13 and iPhone 13 Pro on September 14.

Serum to produce up to 100 mn Covid vaccine doses for India, others

Serum to produce up to 100 mn Covid vaccine doses for India, others

Rediff.com7 Aug 2020

The company has set an affordable ceiling price of USD 3 (around Rs 225) per dose, it added.